{
    "organizations": [],
    "uuid": "1f9febb1a152c37eb4aca4ba428339c918fac74e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-mei-pharma-q2-loss-per-share-016/brief-mei-pharma-q2-loss-per-share-0-16-idUSASB0C4SE",
    "ord_in_thread": 0,
    "title": "BRIEF-MEI Pharma Q2 Loss Per Share $0.16",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 8 (Reuters) - MEI Pharma Inc:\n* MEI PHARMA REPORTS SECOND QUARTER FISCAL YEAR 2018 RESULTS\n* Q2 LOSS PER SHARE $0.16 * ‍AS OF DECEMBER 31, 2017, HAD $42.4 MILLION IN CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS, WITH NO OUTSTANDING DEBT​\n* ‍BELIEVES CASH POSITION WILL BE SUFFICIENT TO FUND OPERATIONS INTO CALENDAR YEAR 2019​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-08T21:24:00.000+02:00",
    "crawled": "2018-02-09T16:25:51.012+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "mei",
        "pharma",
        "inc",
        "mei",
        "pharma",
        "report",
        "second",
        "quarter",
        "fiscal",
        "year",
        "result",
        "q2",
        "loss",
        "per",
        "share",
        "december",
        "million",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "outstanding",
        "cash",
        "position",
        "sufficient",
        "fund",
        "operation",
        "calendar",
        "year",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}